Summary
What do they do? EIN47-3564756. Free individual, couples and group counseling for Bay residents14–26, with postgraduate clinician supervision. Current website says all sessions virtual. More
Why this approach interests us
- Free supervised mental-health care can reduce morbidity when it creates effective treatment beyond available alternatives.
Our main reservations
- Weekly census is not annual treatment completions. Modality, outcomes and gift-created capacity are unverified; favorable world supplies87.1% of expected Bay health.
What do you get for your dollar?
A $10,000 whole gift yields 0.02829 expected Bay QALYs, or $3,535,280 per10, under signed subjective priors. Not measured clinic impact. Inspect the model, assumptions and scenarios.
- weighted bay donor cost per10qalys
- $3,535,280 — Signed expectation before division; all six worlds retained.
- central bay cost per10
- $5,948,461 — Whole FY2024 cash expenses; not program-only.
- complete societal resources
- Unknown — Unpriced donated labor, patient time and complementary care; not a complete societal-cost estimate.
1. What do they do?
EIN47-3564756. Free individual, couples and group counseling for Bay residents14–26, with postgraduate clinician supervision. Current website says all sessions virtual.
Fund whole operations
Charge all345616 FY2024 expense, including318951program and26665administration; no overhead subtraction.
Create or preserve additional therapy
Cash leverage permits reserves, displacement of other giving, supervision limits and funded baseline. Access additionality separately compares alternative care.
Finite net symptom health
Count a bounded benefiting fraction ×utility ×incremental years; deduct independent therapy/delayed-care harm. No suicide mortality credit.
Scope of this review. Cash gift model capped at10000. Existing capacity is an allocation anchor, not a verified new-slot offer. No assurance of linear100000 scaling.
2. Monitoring and information sharing
Greenlight wholeorganization
Original FY2024IRSreturn. 345616expenses;75–80weekly clients; no annual completions.
Our assessment. Credibledatedcost/activity, not treatment-effect or marginal-capacity evidence.
212 adolescents ages 12–18; CBT plus treatment as usual versus treatment as usual
Dickerson et al. randomized trial economic analysis. Reported 12-month gain .067 QALY; 26.8 additional depression-free days × stated .4 utility decrement /365 = .02937 under a simple mapping. The discrepancy remains unreconciled, not a declared source error.
Our assessment. No direct .067 transfer or claim of trial-quality therapy at Greenlight. Finite utility and duration remain analyst judgments; DFD ceiling sensitivity is separate.
470 adolescents randomized to CBT, short-term psychoanalytic therapy or brief psychosocial intervention
IMPACT randomized active-comparator trial. CBT and psychoanalytic therapy did not demonstrate superiority to brief psychosocial intervention.
Our assessment. Effective alternative care may remove incremental benefit. This is not evidence all therapy is ineffective versus no access, nor a clinic-specific null result.
3. Qualitative assessment
Free supervised mental-health care can reduce morbidity when it creates effective treatment beyond available alternatives.
Key reservations
- Annual unique starts, completions, diagnosis mix, attendance and outcome measures unavailable.
- Filing staffing inconsistency:22employees/0volunteers inPartI, volunteerclinicians inPartIII. Do not assume allclinical labor donated.
- No verified current incremental capacity offer; reserve support may only delay later fundraising.
- Clinical effects can vanish against effective alternative care. Soluna coaching is an alternative support, not an assumed therapy substitute.
- Published external .067QALY was not imported; DFD utility mapping requires reconciliation.
- Complete societal resources and counterfactual volunteer use remain unknown.
- FY2024 Form990 expenses are the donor-cost proxy, not a verified2026 cash budget. The20800 government-grant entry is not proof of ongoing public support: beginning other liabilities also20800 fall to zero; grant/debt-forgiveness classification remains unreconciled. No recurring public-displacement amount is inferred.
Benefits not included in our estimate
- No suicide deaths, lifetime relapse prevention, employment/income or school attainment converted to health.
- No added caregiver or training-downstream health; potential benefits remain unquantified.
- No trial medical-cost savings netted from donated cash.
4. What do you get for your dollar?
Census-to-episode-equivalent whole-gift model
75–80 young people weekly is an observed dated census. Active weeks, mean attended weeks, cross-episode dedup and all clinical/counterfactual coefficients are analyst priors locked before execution. Episode equivalents are not observed unique completions; response fraction includes noncompletion and modality mismatch.
A better life is our comparison unit of 10 additional quality-adjusted life years (QALYs), potentially spread across people. These are uncertain estimates, not measured returns or verified donation offers.
How we calculate the estimate
Net Bay health: gift / whole expense × (weekly census × active weeks / attended weeks × dedup) × cash additionality × [access additionality × benefiting fraction × utility × incremental years − harmQ/episode] × Bay share
0.028286302572797566 expected Bay QALYs per$10000
Model inputs and assumptions
- Whole FY2024 expense
- $345,616 (range: Current2026budget unknown). Original IRS return; include all expenses, no program-only discount. High for dated filing.
- Annual treatment-episode equivalents
- 139.5 central (range: 88–237.5 in positive worlds). Observed75–80weekly; assumed44–50weeks,16–30attendedweeks,80–95%dedup. Not annual unique people/completions. Low.
- Cash-created/preserved capacity
- 50% (range: 0–80%). No currentfundingoffer; FY2024netassets237695 anddeficit93689 do not establish gift additionality. Very low.
- Treatment beyond best alternative
- 60% (range: 40–80% in positive worlds). Compare insurance/Medi-Cal, school care, other free clinics and state coaching; not assumed equivalent services. Very low.
- Benefiting fraction × utility × years
- 50% × .06 × .50 (range: Positive worlds35–75% × .04–.10 × .25–.75years). Judgments, not clinic trial measurements. Fraction includes noncompletion and treatment mismatch; duration ends at recovery/equivalent alternative access. Very low.
- Independent harm per delivered episode
- .0005Q (range: 0–.003Q). Signed prior for worsening or delayed appropriate care; not an observed adverse-event rate. Very low.
- Bay-resident health share
- 98% (range: 95–100%). ExplicitBayeligibility; exact patient residence distribution unavailable. Moderate scope; low exact share.
Small unrestricted gift, not earmarked unit purchase
- funding_null: Weight0.2; Not defined per10. NetBayQ0; annualepisodeequivalents139.5. Full coefficients in portable model/results.
- clinical_null: Weight0.15; Not defined per10. NetBayQ0; annualepisodeequivalents139.5. Full coefficients in portable model/results.
- harm: Weight0.1; Not defined per10. NetBayQ-0.0059333190593028095; annualepisodeequivalents139.5. Full coefficients in portable model/results.
- cautious: Weight0.2; $413,416,268 per10. NetBayQ0.00024188694967825563; annualepisodeequivalents88. Full coefficients in portable model/results.
- central: Weight0.25; $5,948,461 per10. NetBayQ0.01681107066802463; annualepisodeequivalents139.5. Full coefficients in portable model/results.
- favorable: Weight0.1; $406,034 per10. NetBayQ0.24628489421786037; annualepisodeequivalents237.5. Full coefficients in portable model/results.
- half_utility_duration: Half utility and half duration. WeightedBayQ0.006267991426901535; $15,954,074 per10. Sensitivity only; base unchanged.
- dfd_mapping: DFD bridge as ceiling sensitivity. WeightedBayQ0.013141921593004008; $7,609,237 per10. Sensitivity only; base unchanged.
- no_favorable: Remove favorable world; renormalize. WeightedBayQ0.004064236834457253; $24,604,865 per10. Sensitivity only; base unchanged.
- full_cash: All cash translates to capacity. WeightedBayQ0.04492242112633675; $2,226,060 per10. Sensitivity only; base unchanged.
- half_access: Half incremental access. WeightedBayQ0.013607428475533544; $7,348,927 per10. Sensitivity only; base unchanged.
- longer_courses: 36 attended weeks per episode. WeightedBayQ0.01339260029756853; $7,466,810 per10. Sensitivity only; base unchanged.
Uncertainty. Prior probability below$1M/10 is10%; below$100k/10 is0%. These are subjective discrete-world masses, not confidence intervals. Harm/null worlds retained. Favorable-tail dependence87.1%.
5. Funding and previous grants
HOLD giving recommendation pending current marginal capacity evidence. Independently audited for exploratory publication, not a verified donation offer.
FY2024revenue251927,expenses345616,netassets237695; governmentgrants20800. Currentcashneed, reserveavailability, pledgedgifts, clinician/supervision slots and2026budget unknown. Website private-only wording is not adopted as fact.
This review does not establish a verified marginal funding offer or a complete history of grants.
Opens the organization’s giving page. A general donation may not fund the specific activity modeled here; confirm allocation with the recipient.
6. Sources
- FY2024 Form 990, filed November 12, 2025. Greenlight Clinic / IRS. Primary return, recovered compressed HTML. Published: 2025-11-12; retrieved: 2026-09-11.
- FY2024 Schedule O. Greenlight Clinic / IRS. Primary return supplement. Published: 2025-11-12; retrieved: 2026-09-11.
- Current service and geographic scope. Greenlight Clinic. Primary organization. Published: Undated; retrieved: 2026-09-11.
- Intake. Greenlight Clinic. Primary organization. Published: Undated; retrieved: 2026-09-11.
- Donation scope. Greenlight Clinic. Primary organization. Published: Undated; retrieved: 2026-09-11.
- CBT economic evaluation in depressed youth declining antidepressants. Dickerson et al., Pediatrics. Primary randomized trial economic analysis. Published: 2018; retrieved: 2026-09-11.
- IMPACT active-comparator adolescent depression trial. Goodyer et al., Lancet Psychiatry. Primary randomized controlled trial. Published: 2017; retrieved: 2026-09-11.
- State-funded virtual behavioral health alternatives. California DHCS. Primary government. Published: Current page includes2026 update; retrieved: 2026-09-11.
Annual expenses: years and sources
Average annual expenses (three consecutive fiscal years): $316,605. Organization size is separate from the modeled cost-effectiveness of a donation.
Greenlight Clinic
Form 990/990-EZ reported whole-entity expenses; includes program, administration and fundraising costs, but excludes any costs netted against revenue.
Latest original return and prior-year comparative combined with earlier filing data.